Idexx Laboratories (IDXX) Short term Debt (2009 - 2026)

Idexx Laboratories has reported Short term Debt for 18 years, with the latest figure at $519.0 million in Q2 2026.

• On a quarterly basis, Short term Debt fell 10.36% year-over-year to $519.0 million in Q2 2026; TTM through Jun 2026 was $519.0 million, a 10.36% decrease from a year earlier, with the FY2025 full-year figure at $398.0 million, up 59.2% from the prior year.
• Short term Debt was $519.0 million for Q2 2026 at Idexx Laboratories, down from $530.0 million in the prior quarter.
• The five-year high for Short term Debt was $633.0 million in Q3 2022, with the low at $250.0 million in Q4 2022.
• Average Short term Debt over 5 years is $382.8 million, with a median of $358.8 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Short term Debt jumped 744.11% in 2022, then tumbled 60.51% in 2023.
• Over 5 years, Short term Debt stood at $250.0 million in 2022, then changed by 0.0% to $250.0 million in 2023, then changed by 0.0% to $250.0 million in 2024, then soared by 59.2% to $398.0 million in 2025, then jumped by 30.4% to $519.0 million in 2026.
• The last three Short term Debt figures came in at $519.0 million (Q2 2026), $530.0 million (Q1 2026), and $398.0 million (Q4 2025), per Business Quant data.